Table 2.
Cancer incidence in first-degree relatives of index cases with breast cancer younger than age 41 but noBRCA1/BRCA2 germline mutation, and at least one additional case of breast cancer in a first-degree or second-degree relative
ICD-7 | Site | Observed (n) | Expected (n) | Standardized incidence ratio | 95% confidence interval |
140–209 | All malignant tumours | 43 | 18.5 | 2.3 | 1.6–3.1 |
Non-170 | All malignant tumours except breast | 29 | 15.9 | 1.8 | 1.2–2.6 |
153 | Large bowel | 1 | 1.2 | 0.82 | 0.02–4.6 |
154 | Rectum | 2 | 0.82 | 2.4 | 0.30–8.8 |
162 | Trachea and lung | 3 | 1.5 | 2.0 | 0.42–5.9 |
170 | Breast | 14 | 2.6 | 5.3 | 2.9–9.0 |
171 | Cervix uteri | 2 | 0.39 | 5.1 | 0.62–18.5 |
175 | Ovaries | 1 | 0.50 | 2.0 | 0.05–11.0 |
177 | Prostate | 6 | 2.4 | 2.5 | 0.91–5.4 |
180 | Kidney | 2 | 0.74 | 2.7 | 0.33–9.8 |
181 | Bladder and urinary tract | 2 | 0.93 | 2.1 | 0.26–7.8 |
191 | Skin nonmelanoma | 1 | 0.50 | 2.0 | 0.05–11.2 |
193 | Central nervous system | 2 | 0.86 | 2.3 | 0.28–8.4 |
200 + 202 | Non-Hodgkin's lymphoma | 3 | 0.66 | 4.5 | 0.94–13.3 |
Age 0–79 years; n = 180; 6885.2 person-years; 1958–2000.